136 related articles for article (PubMed ID: 12376362)
1. Gelatinase activities in the airways of premature infants and development of bronchopulmonary dysplasia.
Danan C; Jarreau PH; Franco ML; Dassieu G; Grillon C; Abd Alsamad I; Lafuma C; Harf A; Delacourt C
Am J Physiol Lung Cell Mol Physiol; 2002 Nov; 283(5):L1086-93. PubMed ID: 12376362
[TBL] [Abstract][Full Text] [Related]
2. MMP-2 and MMP-9 and their tissue inhibitors in the plasma of preterm and term neonates.
Schulz CG; Sawicki G; Lemke RP; Roeten BM; Schulz R; Cheung PY
Pediatr Res; 2004 May; 55(5):794-801. PubMed ID: 14973177
[TBL] [Abstract][Full Text] [Related]
3. Localization and potential role of matrix metalloproteinase-1 and tissue inhibitors of metalloproteinase-1 and -2 in different phases of bronchopulmonary dysplasia.
Dik WA; De Krijger RR; Bonekamp L; Naber BA; Zimmermann LJ; Versnel MA
Pediatr Res; 2001 Dec; 50(6):761-6. PubMed ID: 11726737
[TBL] [Abstract][Full Text] [Related]
4. Low levels of tissue inhibitors of metalloproteinases with a high matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio are present in tracheal aspirate fluids of infants who develop chronic lung disease.
Ekekezie II; Thibeault DW; Simon SD; Norberg M; Merrill JD; Ballard RA; Ballard PL; Truog WE
Pediatrics; 2004 Jun; 113(6):1709-14. PubMed ID: 15173495
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases-2, -8, and -9 and TIMP-2 in tracheal aspirates from preterm infants with respiratory distress.
Cederqvist K; Sorsa T; Tervahartiala T; Maisi P; Reunanen K; Lassus P; Andersson S
Pediatrics; 2001 Sep; 108(3):686-92. PubMed ID: 11533337
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression profiles in tracheal aspirates do not adequately reflect tracheal or lung tissue profiles in neonatal respiratory distress: observations from an animal model.
Miller TL; Touch SM; Shaffer TH
Pediatr Crit Care Med; 2006 Jan; 7(1):63-9. PubMed ID: 16395077
[TBL] [Abstract][Full Text] [Related]
7. MMP-9 and TIMP-1 in the cord blood of premature infants developing BPD.
Fukunaga S; Ichiyama T; Maeba S; Okuda M; Nakata M; Sugino N; Furukawa S
Pediatr Pulmonol; 2009 Mar; 44(3):267-72. PubMed ID: 19205055
[TBL] [Abstract][Full Text] [Related]
8. Regulation of gelatinases in human airway smooth muscle cells: mechanism of progelatinase A activation.
Foda HD; George S; Rollo E; Drews M; Conner C; Cao J; Panettieri RA; Zucker S
Am J Physiol; 1999 Jul; 277(1):L174-82. PubMed ID: 10409245
[TBL] [Abstract][Full Text] [Related]
9. Increased lung matrix metalloproteinase-9 levels in extremely premature baboons with bronchopulmonary dysplasia.
Tambunting F; Beharry KD; Hartleroad J; Waltzman J; Stavitsky Y; Modanlou HD
Pediatr Pulmonol; 2005 Jan; 39(1):5-14. PubMed ID: 15521085
[TBL] [Abstract][Full Text] [Related]
10. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
[TBL] [Abstract][Full Text] [Related]
11. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
[TBL] [Abstract][Full Text] [Related]
12. Low levels of tissue inhibitor of metalloproteinase-2 at birth may be associated with subsequent development of bronchopulmonary dysplasia in preterm infants.
Lee C; An J; Kim JH; Kim ES; Kim SH; Cho YK; Cha DH; Han MY; Lee KH; Sheen YH
Korean J Pediatr; 2015 Nov; 58(11):415-20. PubMed ID: 26692876
[TBL] [Abstract][Full Text] [Related]
13. High concentrations of keratinocyte growth factor in airways of premature infants predicted absence of bronchopulmonary dysplasia.
Danan C; Franco ML; Jarreau PH; Dassieu G; Chailley-Heu B; Bourbon J; Delacourt C
Am J Respir Crit Care Med; 2002 May; 165(10):1384-7. PubMed ID: 12016100
[TBL] [Abstract][Full Text] [Related]
14. Synthetic gelatinases inhibitor attenuates electromagnetic pulse-induced blood-brain barrier disruption by inhibiting gelatinases-mediated ZO-1 degradation in rats.
Qiu LB; Zhou Y; Wang Q; Yang LL; Liu HQ; Xu SL; Qi YH; Ding GR; Guo GZ
Toxicology; 2011 Jul; 285(1-2):31-8. PubMed ID: 21501651
[TBL] [Abstract][Full Text] [Related]
15. Levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are related to cardiopulmonary injury in fetal inflammatory response syndrome.
Yan Y; Jiang L; Li M; Zhang H; Shen Y; Zhang W; Zhang W
Clinics (Sao Paulo); 2020; 75():e2049. PubMed ID: 33263620
[TBL] [Abstract][Full Text] [Related]
16. Decreased homodimerization and increased TIMP-1 complexation of uteroplacental and uterine arterial matrix metalloproteinase-9 during hypertension-in-pregnancy.
Chen J; Ren Z; Zhu M; Khalil RA
Biochem Pharmacol; 2017 Aug; 138():81-95. PubMed ID: 28506758
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase gene polymorphisms and bronchopulmonary dysplasia: identification of MMP16 as a new player in lung development.
Hadchouel A; Decobert F; Franco-Montoya ML; Halphen I; Jarreau PH; Boucherat O; Martin E; Benachi A; Amselem S; Bourbon J; Danan C; Delacourt C
PLoS One; 2008 Sep; 3(9):e3188. PubMed ID: 18784838
[TBL] [Abstract][Full Text] [Related]
18. Expression of tissue inhibitor of metalloproteinase-1, -2, and -3 during neointima formation in organ cultures of human saphenous vein.
Kranzhöfer A; Baker AH; George SJ; Newby AC
Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):255-65. PubMed ID: 9974405
[TBL] [Abstract][Full Text] [Related]
19. Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis.
Oggionni T; Morbini P; Inghilleri S; Palladini G; Tozzi R; Vitulo P; Fenoglio C; Perlini S; Pozzi E
Eur J Histochem; 2006; 50(4):317-25. PubMed ID: 17213041
[TBL] [Abstract][Full Text] [Related]
20. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
